Mycobacterium Tuberculosis Suppresses Host Antimicrobial Peptides by Dehydrogenating L-alanine
Cheng Peng,Yuanna Cheng,Mingtong Ma,Qiu Chen,Yongjia Duan,Shanshan Liu,Hongyu Cheng,Hua Yang,Jingping Huang,Wenyi Bu,Chenyue Shi,Xiangyang Wu,Jianxia Chen,Ruijuan Zheng,Zhonghua Liu,Zhe Ji,Jie Wang,Xiaochen Huang,Peng Wang,Wei Sha,Baoxue Ge,Lin Wang
DOI: https://doi.org/10.1038/s41467-024-48588-4
IF: 16.6
2024-01-01
Nature Communications
Abstract:Antimicrobial peptides (AMPs), ancient scavengers of bacteria, are very poorly induced in macrophages infected by Mycobacterium tuberculosis (M. tuberculosis), but the underlying mechanism remains unknown. Here, we report that L-alanine interacts with PRSS1 and unfreezes the inhibitory effect of PRSS1 on the activation of NF-κB pathway to induce the expression of AMPs, but mycobacterial alanine dehydrogenase (Ald) Rv2780 hydrolyzes L-alanine and reduces the level of L-alanine in macrophages, thereby suppressing the expression of AMPs to facilitate survival of mycobacteria. Mechanistically, PRSS1 associates with TAK1 and disruptes the formation of TAK1/TAB1 complex to inhibit TAK1-mediated activation of NF-κB pathway, but interaction of L-alanine with PRSS1, disables PRSS1-mediated impairment on TAK1/TAB1 complex formation, thereby triggering the activation of NF-κB pathway to induce expression of AMPs. Moreover, deletion of antimicrobial peptide gene β-defensin 4 (Defb4) impairs the virulence by Rv2780 during infection in mice. Both L-alanine and the Rv2780 inhibitor, GWP-042, exhibits excellent inhibitory activity against M. tuberculosis infection in vivo. Our findings identify a previously unrecognized mechanism that M. tuberculosis uses its own alanine dehydrogenase to suppress host immunity, and provide insights relevant to the development of effective immunomodulators that target M. tuberculosis.